Profil
Min MIn Qin is currently the Chief Technology Officer at Lepu Biopharma Co., Ltd. and the Senior Vice President at Shanghai Miracogen, Inc. Previously, Dr. Qin held positions such as Senior Director-Process Development at BioMarin Pharmaceutical, Inc. from 1997 to 2004, Senior Director at Five Prime Therapeutics, Inc. from 2005 to 2012, Vice President at Wuxi Biologics (Cayman), Inc. from 2017 to 2018, Senior Vice President at HBM Holdings Ltd. from 2018 to 2019, Chief Technology Officer at Shanghai JMT-BIO Technology Co., Ltd. from 2012 to 2015, Chief Technology Officer & Senior Vice President at Zhejiang Teruisi Pharmaceutical Co., Ltd. from 2015 to 2016, and Chief Science Officer at Jiangsu Pacific Meinuoke Pharmaceutical Co. Ltd. from 2016 to 2017.
Dr. Qin obtained a doctorate degree from the University of Wisconsin in 1991 and an undergraduate degree from Northwest A&F University in 1981.
Aktive Positionen von Min MIn Qin
| Unternehmen | Position | Beginn |
|---|---|---|
| LEPU BIOPHARMA CO., LTD. | Technik-/Wissenschafts-/F&E-Leiter | 10.12.2020 |
Shanghai Miracogen, Inc.
Shanghai Miracogen, Inc. BiotechnologyHealth Technology Engages in development, clinical research and industrialization of cancer targeted therapy drugs | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Min MIn Qin
| Unternehmen | Position | Ende |
|---|---|---|
| HBM HOLDINGS LIMITED | Corporate Officer/Principal | 01.04.2019 |
| WUXI BIOLOGICS (CAYMAN) INC. | Corporate Officer/Principal | 01.03.2018 |
Jiangsu Pacific Meinuoke Pharmaceutical Co. Ltd. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2017 |
Zhejiang Teruisi Pharmaceutical Co., Ltd.
Zhejiang Teruisi Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Engages in production of cancer medicine | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2016 |
Shanghai JMT-BIO Technology Co., Ltd. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2015 |
Ausbildung von Min MIn Qin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Five Prime Therapeutics, Inc.
Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northwest A&F University
Northwest A&F University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wuxi Biologics (Cayman), Inc.
Wuxi Biologics (Cayman), Inc. BiotechnologyHealth Technology Engages in discovery, development and manufacturing of biologics | Health Technology |
HBM Holdings Ltd.
HBM Holdings Ltd. Pharmaceuticals: OtherHealth Technology Engages in research and development of therapeutics in the fields of immuno-oncology and immunology diseases | Health Technology |
Shanghai JMT-BIO Technology Co., Ltd. | |
Lepu Biopharma Co., Ltd.
Lepu Biopharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Shanghai Miracogen, Inc.
Shanghai Miracogen, Inc. BiotechnologyHealth Technology Engages in development, clinical research and industrialization of cancer targeted therapy drugs | Health Technology |
Zhejiang Teruisi Pharmaceutical Co., Ltd.
Zhejiang Teruisi Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Engages in production of cancer medicine | Health Technology |
Jiangsu Pacific Meinuoke Pharmaceutical Co. Ltd. |
















